Molecular approaches to potentiate cisplatin responsiveness in carcinoma therapeutics
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Molecular approaches to potentiate cisplatin responsiveness in carcinoma therapeutics
Authors
Keywords
-
Journal
Expert Review of Anticancer Therapy
Volume 17, Issue 9, Pages 815-825
Publisher
Informa UK Limited
Online
2017-07-14
DOI
10.1080/14737140.2017.1356231
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Smart nanoparticles improve therapy for drug-resistant tumors by overcoming pathophysiological barriers
- (2016) Jian-ping Liu et al. ACTA PHARMACOLOGICA SINICA
- Lifeguard inhibition of Fas-mediated apoptosis: A possible mechanism for explaining the cisplatin resistance of triple-negative breast cancer cells
- (2016) Daniel Radin et al. BIOMEDICINE & PHARMACOTHERAPY
- Triapine potentiates platinum-based combination therapy by disruption of homologous recombination repair
- (2016) Elena S Ratner et al. BRITISH JOURNAL OF CANCER
- Translational regulation of the mRNA encoding the ubiquitin peptidase USP1 involved in the DNA damage response as a determinant of Cisplatin resistance
- (2016) Tony Sourisseau et al. CELL CYCLE
- Molecular Pathways: Emergence of Protein Kinase CK2 (CSNK2) as a Potential Target to Inhibit Survival and DNA Damage Response and Repair Pathways in Cancer Cells
- (2016) A. J. Rabalski et al. CLINICAL CANCER RESEARCH
- Biomarkers of Response and Resistance to DNA Repair Targeted Therapies
- (2016) E. H. Stover et al. CLINICAL CANCER RESEARCH
- Clinical proteomics-driven precision medicine for targeted cancer therapy: current overview and future perspectives
- (2016) Li Zhou et al. Expert Review of Proteomics
- Platinum anti-cancer drugs: Free radical mechanism of Pt-DNA adduct formation and anti-neoplastic effect
- (2016) Clifford W. Fong FREE RADICAL BIOLOGY AND MEDICINE
- Role of the tumor microenvironment in pancreatic adenocarcinoma
- (2016) Ai-wu Mao Frontiers in Bioscience-Landmark
- New design of nucleotide excision repair (NER) inhibitors for combination cancer therapy
- (2016) Francesco Gentile et al. JOURNAL OF MOLECULAR GRAPHICS & MODELLING
- Cisplatin resistance and opportunities for precision medicine
- (2016) Lauren Amable PHARMACOLOGICAL RESEARCH
- MiRNAs-mediated cisplatin resistance in breast cancer
- (2016) Xiu Chen et al. TUMOR BIOLOGY
- NEAT1 upregulates EGCG-induced CTR1 to enhance cisplatin sensitivity in lung cancer cells
- (2016) Pan Jiang et al. Oncotarget
- Pre-clinical efficacy and synergistic potential of the MDM2-p53 antagonists, Nutlin-3 and RG7388, as single agents and in combined treatment with cisplatin in ovarian cancer
- (2016) Maryam Zanjirband et al. Oncotarget
- Yu Ping Feng San reverses cisplatin-induced multi-drug resistance in lung cancer cells via regulating drug transporters and p62/TRAF6 signalling
- (2016) Jian-Shu Lou et al. Scientific Reports
- Cisplatin Prodrug-Conjugated Gold Nanocluster for Fluorescence Imaging and Targeted Therapy of the Breast Cancer
- (2016) Fangyuan Zhou et al. Theranostics
- Targeted delivery of cisplatin by LHRH-peptide conjugated dextran nanoparticles suppresses breast cancer growth and metastasis
- (2015) Mingqiang Li et al. Acta Biomaterialia
- Chemical inhibitor targeting the replication protein A–DNA interaction increases the efficacy of Pt-based chemotherapy in lung and ovarian cancer
- (2015) Akaash K. Mishra et al. BIOCHEMICAL PHARMACOLOGY
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Inhibition of protein phosphatase 2A with the small molecule LB100 overcomes cell cycle arrest in osteosarcoma after cisplatin treatment
- (2015) Chao Zhang et al. CELL CYCLE
- Role of mismatch repair proteins in the processing of cisplatin interstrand cross-links
- (2015) Akshada Sawant et al. DNA REPAIR
- UCP2 inhibition sensitizes breast cancer cells to therapeutic agents by increasing oxidative stress
- (2015) Daniel Gabriel Pons et al. FREE RADICAL BIOLOGY AND MEDICINE
- miR-214: a potential biomarker and therapeutic for different cancers
- (2015) Tanu Sharma et al. Future Oncology
- Pharmacologic inhibition of ATR and ATM offers clinically important distinctions to enhancing platinum or radiation response in ovarian, endometrial, and cervical cancer cells
- (2015) Pang-ning Teng et al. GYNECOLOGIC ONCOLOGY
- Novel delivery approaches for cancer therapeutics
- (2015) Ashim K. Mitra et al. JOURNAL OF CONTROLLED RELEASE
- The role of Ctr1 and Ctr2 in mammalian copper homeostasis and platinum-based chemotherapy
- (2015) Helena Öhrvik et al. JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY
- An integrated view of cisplatin-induced nephrotoxicity and ototoxicity
- (2015) Takatoshi Karasawa et al. TOXICOLOGY LETTERS
- miR-27a regulates the sensitivity of breast cancer cells to cisplatin treatment via BAK-SMAC/DIABLO-XIAP axis
- (2015) Sumei Zhou et al. TUMOR BIOLOGY
- MiR-944 functions as a novel oncogene and regulates the chemoresistance in breast cancer
- (2015) Haifei He et al. TUMOR BIOLOGY
- Knockdown of miR-221 promotes the cisplatin-inducing apoptosis by targeting the BIM-Bax/Bak axis in breast cancer
- (2015) Zhiqiang Ye et al. TUMOR BIOLOGY
- miR-302b enhances breast cancer cell sensitivity to cisplatin by regulating E2F1 and the cellular DNA damage response
- (2015) Alessandra Cataldo et al. Oncotarget
- miR-134 in extracellular vesicles reduces triple-negative breast cancer aggression and increases drug sensitivity
- (2015) Keith O’Brien et al. Oncotarget
- EGCG Enhances Cisplatin Sensitivity by Regulating Expression of the Copper and Cisplatin Influx Transporter CTR1 in Ovary Cancer
- (2015) Xuemin Wang et al. PLoS One
- Silencing of CXCR4 sensitizes triple-negative breast cancer cells to cisplatin
- (2015) Sixian Liang et al. Oncotarget
- Overexpression of CXCR4 is significantly associated with cisplatin-based chemotherapy resistance and can be a prognostic factor in epithelial ovarian cancer
- (2014) Jia Li et al. BMB Reports
- Expression of a novel peptide derived from PCNA damages DNA and reverses cisplatin resistance
- (2014) Robert G. Lingeman et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- A Small Molecule Screen Identifies an Inhibitor of DNA Repair Inducing the Degradation of TFIIH and the Chemosensitization of Tumor Cells to Platinum
- (2014) Sergey Alekseev et al. CHEMISTRY & BIOLOGY
- Cisplatin in cancer therapy: Molecular mechanisms of action
- (2014) Shaloam Dasari et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Wortmannin potentiates the combined effect of etoposide and cisplatin in human glioma cells
- (2014) Elzbieta Pastwa et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- New therapeutic perspectives in CCDC6 deficient lung cancer cells
- (2014) Francesco Morra et al. INTERNATIONAL JOURNAL OF CANCER
- A Small Molecule Inhibitor of Monoubiquitinated Proliferating Cell Nuclear Antigen(PCNA) Inhibits Repair of Interstrand DNA Cross-link, Enhances DNA Double Strand Break, and Sensitizes Cancer Cells to Cisplatin
- (2014) Akira Inoue et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MiR-363 sensitizes cisplatin-induced apoptosis targeting in Mcl-1 in breast cancer
- (2014) Ruiguang Zhang et al. MEDICAL ONCOLOGY
- Mechanisms of cell uptake and toxicity of the anticancer drug cisplatin
- (2014) Nasma D. Eljack et al. Metallomics
- Targeting BRCA1-BER deficient breast cancer by ATM or DNA-PKcs blockade either alone or in combination with cisplatin for personalized therapy
- (2014) Nada Albarakati et al. Molecular Oncology
- A Small Molecule Inhibitor of Human RAD51 Potentiates Breast Cancer Cell Killing by Therapeutic Agents in Mouse Xenografts
- (2014) Fei Huang et al. PLoS One
- Cisplatin targets the stromal cell-derived factor-1-CXC chemokine receptor type 4 axis to suppress metastasis and invasion of ovarian cancer-initiating cells
- (2014) Zhi-hua Yu et al. TUMOR BIOLOGY
- Translocation of Platinum Anticancer Drugs by Human Copper ATPases ATP7A and ATP7B
- (2013) Francesco Tadini-Buoninsegni et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Small molecule inhibitors of PCNA/PIP-box interaction suppress translesion DNA synthesis
- (2013) Marcelo Actis et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Vitamin B6 metabolism influences the intracellular accumulation of cisplatin
- (2013) Lorenzo Galluzzi et al. CELL CYCLE
- The mammalian copper transporters CTR1 and CTR2 and their roles in development and disease
- (2013) Natalie K.Y. Wee et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Emodin affects ERCC1 expression in breast cancer cells
- (2013) Jian-min Fu et al. Journal of Translational Medicine
- Direct intercalation of cisplatin into zirconium phosphate nanoplatelets for potential cancer nanotherapy
- (2013) Agustín Díaz et al. Nanoscale
- Epistatic role of base excision repair and mismatch repair pathways in mediating cisplatin cytotoxicity
- (2013) Anbarasi Kothandapani et al. NUCLEIC ACIDS RESEARCH
- Mesoporous Silica Nanoparticles: Synthesis, Biocompatibility and Drug Delivery
- (2012) Fangqiong Tang et al. ADVANCED MATERIALS
- Recognition of Platinum–DNA Adducts by HMGB1a
- (2012) Srinivas Ramachandran et al. BIOCHEMISTRY
- Sequence-Specific Recognition of Cancer Drug-DNA Adducts by HMGB1a Repair Protein
- (2012) Robert M. Elder et al. BIOPHYSICAL JOURNAL
- Role of the Human High-Affinity Copper Transporter in Copper Homeostasis Regulation and Cisplatin Sensitivity in Cancer Chemotherapy
- (2012) M. T. Kuo et al. CANCER RESEARCH
- Pathophysiological roles of aldo–keto reductases (AKR1C1 and AKR1C3) in development of cisplatin resistance in human colon cancers
- (2012) Toshiyuki Matsunaga et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Role of PARP Inhibitors in Cancer Biology and Therapy
- (2012) D. Davar et al. CURRENT MEDICINAL CHEMISTRY
- The molecular origin of the MMR-dependent apoptosis pathway from dynamics analysis of MutSα-DNA complexes
- (2012) Lacramioara Negureanu et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Decreased expression of C-erbB-2 and CXCR4 in breast cancer after primary chemotherapy
- (2012) Shi-Xin Yang et al. Journal of Translational Medicine
- Interferon regulatory factor 4 binding protein is a novel p53 target gene and suppresses cisplatin-induced apoptosis of breast cancer cells
- (2012) Mingzhen Yang et al. Molecular Cancer
- Overcoming Platinum Resistance through the Use of a Copper-Lowering Agent
- (2012) Siqing Fu et al. MOLECULAR CANCER THERAPEUTICS
- Mechanistic Basis for Overcoming Platinum Resistance Using Copper Chelating Agents
- (2012) Z. D. Liang et al. MOLECULAR CANCER THERAPEUTICS
- Upregulation of CXCR4 is functionally crucial for maintenance of stemness in drug-resistant non-small cell lung cancer cells
- (2012) M-J Jung et al. ONCOGENE
- Cholesterol-tethered platinum II-based supramolecular nanoparticle increases antitumor efficacy and reduces nephrotoxicity
- (2012) P. Sengupta et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mitochondrial recoupling: a novel therapeutic strategy for cancer?
- (2011) G Baffy et al. BRITISH JOURNAL OF CANCER
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Selective and Cell-Active Inhibitors of the USP1/ UAF1 Deubiquitinase Complex Reverse Cisplatin Resistance in Non-small Cell Lung Cancer Cells
- (2011) Junjun Chen et al. CHEMISTRY & BIOLOGY
- XPF Expression Correlates with Clinical Outcome in Squamous Cell Carcinoma of the Head and Neck
- (2011) Alec Vaezi et al. CLINICAL CANCER RESEARCH
- Epigenetic modifications in cancer
- (2011) R Kanwal et al. CLINICAL GENETICS
- New Aspects of Mitochondrial Uncoupling Proteins (UCPs) and Their Roles in Tumorigenesis
- (2011) Delira Robbins et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Novel Role of Base Excision Repair in Mediating Cisplatin Cytotoxicity
- (2011) Anbarasi Kothandapani et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Novel Irreversible Small Molecule Inhibitors of Replication Protein A Display Single-Agent Activity and Synergize with Cisplatin
- (2011) T. M. Neher et al. MOLECULAR CANCER THERAPEUTICS
- Mesoporous silica nanoparticles for bioadsorption, enzyme immobilisation, and delivery carriers
- (2011) Amirali Popat et al. Nanoscale
- Molecular mechanisms of cisplatin resistance
- (2011) L Galluzzi et al. ONCOGENE
- Nanoparticle-based theranostic agents
- (2010) Jin Xie et al. ADVANCED DRUG DELIVERY REVIEWS
- Rapamycin synergizes cisplatin sensitivity in basal-like breast cancer cells through up-regulation of p73
- (2010) Su Wei Wong et al. BREAST CANCER RESEARCH AND TREATMENT
- Marked anti-tumour activity of the combination of YM155, a novel survivin suppressant and platinum-based drugs
- (2010) T Iwasa et al. BRITISH JOURNAL OF CANCER
- Treatment of triple negative breast cancer (TNBC): current options and future perspectives
- (2010) M. De Laurentiis et al. CANCER TREATMENT REVIEWS
- CXCL12 (SDF-1)/CXCR4 Pathway in Cancer
- (2010) B. A. Teicher et al. CLINICAL CANCER RESEARCH
- Downregulation of XPF–ERCC1 enhances cisplatin efficacy in cancer cells☆
- (2010) Sanjeevani Arora et al. DNA REPAIR
- Alterations of microRNAs and their targets are associated with acquired resistance of MCF-7 breast cancer cells to cisplatin
- (2010) Igor P. Pogribny et al. INTERNATIONAL JOURNAL OF CANCER
- FOXM1 Confers Acquired Cisplatin Resistance in Breast Cancer Cells
- (2010) J. M.-M. Kwok et al. MOLECULAR CANCER RESEARCH
- The Role of the Methionines and Histidines in the Transmembrane Domain of Mammalian Copper Transporter 1 in the Cellular Accumulation of Cisplatin
- (2010) C. A. Larson et al. MOLECULAR PHARMACOLOGY
- Copper Transporters and the Cellular Pharmacology of the Platinum-Containing Cancer Drugs
- (2010) S. B. Howell et al. MOLECULAR PHARMACOLOGY
- Triple-Negative Breast Cancer
- (2010) William D. Foulkes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Metallofullerene nanoparticles circumvent tumor resistance to cisplatin by reactivating endocytosis
- (2010) X.-J. Liang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Negative regulation of UCP2 by TGFβ signaling characterizes low and intermediate-grade primary breast cancer
- (2010) A Sayeed et al. Cell Death & Disease
- Copper Transporter 2 Regulates the Cellular Accumulation and Cytotoxicity of Cisplatin and Carboplatin
- (2009) B. G. Blair et al. CLINICAL CANCER RESEARCH
- Targeting superoxide dismutase 1 to overcome cisplatin resistance in human ovarian cancer
- (2008) Dawn P. G. Brown et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Lentivirus-mediated RNAi silencing targeting ABCC2 increasing the sensitivity of a human nasopharyngeal carcinoma cell line against cisplatin
- (2008) Si Xie et al. Journal of Translational Medicine
- The Role of the Mammalian Copper Transporter 1 in the Cellular Accumulation of Platinum-Based Drugs
- (2008) C. A. Larson et al. MOLECULAR PHARMACOLOGY
- Transcription Factor Sp1 Plays an Important Role in the Regulation of Copper Homeostasis in Mammalian Cells
- (2008) I.-S. Song et al. MOLECULAR PHARMACOLOGY
- The Role of Cellular Accumulation in Determining Sensitivity to Platinum-Based Chemotherapy
- (2007) Matthew D. Hall et al. Annual Review of Pharmacology and Toxicology
- Clinical relevance of the homologous recombination machinery in cancer therapy
- (2007) Kiyoshi Miyagawa CANCER SCIENCE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started